Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)
CUSIP: 501147102
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.00001 par value ("Common Stock")
- Shares outstanding
- 29,463,330
- Total 13F shares
- 27,774,030
- Share change
- -537,627
- Total reported value
- $4,351,782,009
- Put/Call ratio
- 60%
- Price per share
- $156.66
- Number of holders
- 264
- Value change
- -$92,533,890
- Number of buys
- 123
- Number of sells
- 146
Quarterly Holders Quick Answers
What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501147102:
Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
15%
|
4,292,881
|
$781,433,128 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
14%
|
3,993,123
|
$726,868,180 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.7%
|
2,849,744
|
$518,738,900 | — | 30 Sep 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
8.9%
|
2,622,222
|
$477,323,071 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
4.4%
from 13D/G
|
1,452,811
|
$264,455,186 | — | 30 Sep 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.4%
|
988,460
|
$179,929,374 | — | 30 Sep 2024 | |
| Capital World Investors |
13F
|
Company |
3%
|
879,083
|
$160,019,478 | — | 30 Sep 2024 | |
| Redmile Group, LLC |
13F
|
Company |
2.8%
|
810,245
|
$147,488,897 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2%
|
600,261
|
$109,259,856 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
591,631
|
$107,714,350 | — | 30 Sep 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.7%
|
502,104
|
$91,397,991 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.5%
|
438,259
|
$79,777,000 | — | 30 Sep 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.4%
|
410,057
|
$74,642,675 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.2%
|
365,551
|
$66,541,249 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.1%
|
311,855
|
$56,766,966 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
301,354
|
$54,855,469 | — | 30 Sep 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.96%
|
284,159
|
$51,726,000 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.94%
|
275,804
|
$50,204,669 | — | 30 Sep 2024 | |
| NORGES BANK |
13F
|
Company |
0.83%
|
244,097
|
$44,432,977 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.83%
|
243,760
|
$43,774,421 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.82%
|
240,216
|
$43,726,518 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
238,691
|
$43,448,922 | — | 30 Sep 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.76%
|
224,945
|
$40,946,739 | — | 30 Sep 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.74%
|
216,979
|
$39,496,687 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.61%
|
179,815
|
$32,731,724 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.58%
|
171,653
|
$31,246,059 | — | 30 Sep 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.58%
|
169,934
|
$30,933,086 | — | 30 Sep 2024 | |
| BRAIDWELL LP |
13F
|
Company |
0.57%
|
168,691
|
$30,706,823 | — | 30 Sep 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.55%
|
163,304
|
$29,726,227 | — | 30 Sep 2024 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.53%
|
157,144
|
$28,604,922 | — | 30 Sep 2024 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.46%
|
135,809
|
$24,721,000 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.43%
|
127,901
|
$23,281,819 | — | 30 Sep 2024 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.43%
|
126,082
|
$22,950,706 | — | 30 Sep 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.41%
|
119,726
|
$21,793,724 | — | 30 Sep 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.39%
|
115,350
|
$20,997,161 | — | 30 Sep 2024 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.39%
|
114,222
|
$20,791,831 | — | 30 Sep 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.38%
|
111,705
|
$20,333,619 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.36%
|
104,654
|
$19,050,168 | — | 30 Sep 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.33%
|
98,285
|
$17,890,818 | — | 30 Sep 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
95,781
|
$17,435,015 | — | 30 Sep 2024 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.32%
|
94,700
|
$17,238,000 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.3%
|
89,749
|
$16,337,011 | — | 30 Sep 2024 | |
| S Squared Technology, LLC |
13F
|
Company |
0.26%
|
75,215
|
$13,691,386 | — | 30 Sep 2024 | |
| Decheng Capital LLC |
13F
|
Company |
0.24%
|
71,772
|
$13,064,657 | — | 30 Sep 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.24%
|
70,578
|
$12,847,314 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.24%
|
70,309
|
$12,798,323 | — | 30 Sep 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.22%
|
63,602
|
$12,695,595 | — | 30 Sep 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.23%
|
67,942
|
$12,367,482 | — | 30 Sep 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.22%
|
66,255
|
$12,060,397 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.19%
|
56,540
|
$10,291,977 | — | 30 Sep 2024 |
Institutional Holders of Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) as of Q4 2024
As of 31 Dec 2024,
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) was held by
264 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,774,030 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Capital World Investors, Frazier Life Sciences Management, L.P., Redmile Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
264
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
281
Q4 2024 holders
264
Holder diff
-17
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.